Judges Scientific Regulatory News (JDG)

Judges Scientific plc ("Judges" or the "Company")

Director/PDMR Shareholding

21 August 2012

Further to the announcement of 22 June 2012, the Company announces that, following the conversion by David Cicurel, the CEO of Judges, of 2,907,870 convertible redeemable shares of 1p each, the Company has today issued to him 377,229 ordinary shares of 5p each ("Ordinary Shares"). The amount payable by David Cicurel (95p per new Ordinary Share less the nominal value of the convertible redeemable shares converted) is equal to the amount receivable by him in respect of share redemptions which were also referred to in the 22 June 2012 announcement. Thus these two transactions, when taken together, are cash-neutral for the Company.

Shareholding

Following this conversion, David Cicurel is now interested in 916,070 Ordinary Shares (including 82,885 held in his SIPP) representing approximately 17.52% of the issued ordinary share capital.

Admission

Application has been made to the London Stock Exchange for the Ordinary Shares to be admitted to trading on the Alternative Investment Market ("AIM") and admission is expected to take place on 22 August 2012. The Ordinary Shares will rank pari passu with the existing Ordinary Shares.

Total voting rights

Following admission of the Ordinary Shares, the issued share capital will be 5,228,196 Ordinary Shares. The Company does not hold any shares in treasury and the above figure may therefore be used by shareholders as the denominator for the calculation to determine whether they are required to notify their interest in, or a change to their interest in, the Company under the Financial Services Authority's Disclosure and Transparency Rules.

Enquiries:

Judges Scientific plc

David Cicurel, CEO

01342 323 600

Shore Capital

Pascal Keane

Edward Mansfield

020 7408 4090

Cardew Group

Melvyn Marckus

07775 896491